OE™ Embedded Edition, a package of its Agentix Operating Engine and a set of purpose-built tools for the AMD Ryzen™ AI Embedded X100 Series processor, the newest processor in a family designed for ...

Boyd Watterson Global today announced the appointment of John Creswell as Global Chief Client Officer, a newly created senior ...

As a global leader in HIV and STI prevention and treatment, AIDS Healthcare Foundation (AHF) is once again bringing a bold and provocative message to the 26th International AIDS Conference (AIDS 2026) ...

Humanoid, a UK-based AI and robotics company building industrial humanoid robots, announced a $152 million Series A financing ...

Competing against 36 leading contenders from 20 countries, four Taiwanese children’s choirs have garnered several major awards and top honors at the 5th Budapest International Choral Celebration, ...

The Prague Folklore Days 2026 was held on July 17 and 18 in the heart of Prague, bringing together 56 international arts groups from Germany, Austria, Slovakia, Spain, the Netherlands, and Poland.

Airship, the mobile-first customer experience platform leader, today announced its Airship Results Guarantee, a corporate ...

Timeline (Amazentis SA), the Swiss life-sciences company that pioneered the postbiotic ingredient Urolithin A and its branded form Mitopure®, together with its U.S. subsidiary Timeline Longevity, Inc.

TestMu AI (formerly LambdaTest), the world's first Agentic AI-powered Quality Engineering platform, introduced a source-to-verdict loop in Kane CLI, its natural-language testing tool. Building on Kane ...

Wolters Kluwer Healt h announced that Norway’s health system has renewed its adoption of UpToDate Enterprise Edition, a market-leading Clinical Decision Support (CDS) solution, for its nationwide ...

Galderma Group AG (SIX: GALD), the pure-play dermatology category leader, today announced its financial results for the first half of 2026. Galderma is on a strong trajectory in 2026 to deliver on ...

Azafaros, a private company building a portfolio of disease-modifying therapeutics to become a leader in lysosomal storage disorders (LSDs) focused on addressing neurological symptoms, today announced ...